PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.71%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.36%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-17.14%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-16.80%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-17.89%
Negative net income growth while 2127.T stands at 2.95%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.88%
Negative EPS growth while 2127.T is at 2.91%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.88%
Negative diluted EPS growth while 2127.T is at 5.14%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 2127.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
27.78%
10Y revenue/share CAGR under 50% of 2127.T's 160.97%. Michael Burry would suspect a lasting competitive disadvantage.
-5.26%
Negative 5Y CAGR while 2127.T stands at 123.97%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-31.58%
Negative 3Y CAGR while 2127.T stands at 63.66%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
99.93%
Below 50% of 2127.T's 303.63%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
12.21%
Below 50% of 2127.T's 187.21%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-34.86%
Negative 3Y CAGR while 2127.T is 92.90%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
94.36%
Equity/share CAGR of 94.36% while 2127.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
32.39%
Below 50% of 2127.T's 183.85%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-14.03%
Negative 3Y equity/share growth while 2127.T is at 101.83%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.00%
Negative near-term dividend growth while 2127.T invests at 128.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
14.81%
AR growth of 14.81% while 2127.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
8.28%
Inventory shrinking or stable vs. 2127.T's 62.00%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
9.75%
Similar asset growth to 2127.T's 10.09%. Walter Schloss finds parallel expansions or investment rates.
4.09%
Under 50% of 2127.T's 8.63%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
113.93%
Debt growth of 113.93% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
2.04%
SG&A declining or stable vs. 2127.T's 4.18%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.